SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000921895-22-002146
Filing Date
2022-07-05
Accepted
2022-07-05 16:52:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D sc13d13392003_07052022.htm SC 13D 109182
  Complete submission text file 0000921895-22-002146.txt   110784
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Subject) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89959 | Film No.: 221065917
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2261 MARKET STREET #4307 SAN FRANCISCO CA 94114
Business Address 2261 MARKET STREET #4307 SAN FRANCISCO CA 94114 4158571965
Funicular Fund, LP (Filed by) CIK: 0001752618 (see all company filings)

IRS No.: 831460042 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D